Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss

Transplant Immunology

Volumn 29, Issue 1-4, 2013, Pages 22-27

  Fidler, Samantha ^a,b   Swaminathan, Ramyasuda ^a,c   Lim, Wai ^d   Ferrari, Paolo ^e   Witt, Campbell ^a,b   Christiansen, Frank T ^a,b   D'Orsogna, Lloyd J ^a,b   Irish, Ashley B ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e FREMANTLE HOSPITAL   (Australia)

Author keywords

Antibody mediated rejection; Donor specific antibody (DSA); Kidney transplantation; Peri operative transfusion

Indexed keywords

HLA ANTIBODY;

ADULT; ANTIBODY MEDIATED REJECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; IMMUNOSTIMULATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL PREDICTION;

AMR; ANTIBODY MEDIATED REJECTION; ANTIBODY-MEDIATED REJECTION; BIOPSY PROVEN ACUTE REJECTION; BPAR; CALCULATED PANEL REACTIVE ANTIBODY; CPRA; DELAYED GRAFT FUNCTION; DGF; DONOR SPECIFIC ANTIBODIES; DONOR-SPECIFIC ANTIBODY (DSA); DSA; KIDNEY TRANSPLANTATION; MEAN FLUORESCENCE INTENSITY; MFI; PERI-OPERATIVE TRANSFUSION; RBCT; RED BLOOD CELL TRANSFUSION; SAB; SINGLE ANTIGEN BEAD;

ADULT; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RISK FACTORS;

EID: 84897061554     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.09.008     Document Type: Article

References (38)

1. Lefaucheur C., Loupy A., Hill G.S., Andrade J., Nochy D., Antoine C., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21:1398-1406.
2. Otten H.G., Verhaar M.C., Borst H.P., Hene R.J., van Zuilen A.D. Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure. Am J Transplant 2012, 12:1618-1623.
3. Song E.Y., Lee Y.J., Hyun J., Kim Y.S., Ahn C., Ha J., et al. Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches. Ann Lab Med 2012, 32:139-144.
4. Opelz G., Graver B., Mickey M.R., Terasaki P.I. Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 1981, 32:177-183.
5. Sanfilippo F., Vaughn W.K., Bollinger R.R., Spees E.K. The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. Transplantation 1984, 37:350-356.
6. Scornik J.C., Ireland J.E., Howard R.J., Fennell R.S., Pfaff W.W. Role of regular and leukocyte-free blood transfusions in the generation of broad sensitization. Transplantation 1984, 38:594-598.
7. Pfaff W.W., Howard R.J., Scornik J.C., Day C., Renderer J., Scott J., et al. Incidental and purposeful random donor blood transfusion. Sensitization and transplantation. Transplantation 1989, 47:130-133.
8. Chow M.P., Hu H.Y., Lyou J.Y., Lin J.S., Yung C.H., Lee A., et al. Red cells, HLA and platelet antibody formation in patients with multiple transfusions. Acta Haematol 1994, 92:57-60.
9. Novotny V.M., van Doorn R., Witvliet M.D., Claas F.H., Brand A. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood 1995, 85:1736-1741.
10. Blajchman M.A. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998, 74(Suppl. 2):315-319.
11. Claas F.H., Roelen D.L., van Rood J.J., Brand A. Modulation of the alloimmune response by blood transfusions. Transfus Clin Biol 2001, 8:315-317.
12. Opelz G., Graver B., Terasaki P.I. Induction of high kidney graft survival rate by multiple transfusion. Lancet 1981, 1:1223-1225.
13. Scornik J.C., Meier-Kriesche H.U. Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant 2011, 11:1785-1791.
14. Karpinski M., Pochinco D., Dembinski I., Laidlaw W., Zacharias J., Nickerson P. Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J Am Soc Nephrol 2004, 15:818-824.
15. Scornik J.C., Pfaff W.W., Howard R.J., Fennell R.S., Ramos E., Peterson J.C., et al. Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 1994, 58:1361-1365.
16. Scornik J.C., Ireland J.E., Howard R.J., Pfaff W.W. Assessment of the risk for broad sensitization by blood transfusions. Transplantation 1984, 37:249-253.
17. Sanfilippo F., Vaughn W.K., Bollinger R.R., Spees E.K. Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation 1982, 34:360-366.
18. Fox K.M., Yee J., Cong Z., Brooks J.M., Petersen J., Lamerato L., et al. Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study. BMC Nephrol 2012, 13:5.
19. Ibrahim H.N., Skeans M.A., Li Q., Ishani A., Snyder J.J. Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes. Clin Transpl 2011, 25:653-659.
20. Aalten J., Bemelman F.J., van den Berg-Loonen E.M., Claas F.H., Christiaans M.H., de Fijter J.W., et al. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Nephrology, dialysis, transplantation. Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 2009, 24:2559-2566.
21. Balasubramaniam G.S., Morris M., Gupta A., Mesa I.R., Thuraisingham R., Ashman N. Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion. Transplantation 2012, 93:418-422.
22. Scornik J.C. Leukoreduced blood and sensitization of organ transplant candidates. Transfusion 2012, 52:1838-1839. [author reply 9].
23. van de Watering L., Hermans J., Witvliet M., Versteegh M., Brand A. HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 2003, 43:765-771.
24. AlMahri A., Holgersson J., Alheim M. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry. Tissue Antigens 2012, 80:404-415.
25. Chen G., Sequeira F., Tyan D.B. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011, 72:849-858.
26. Mujtaba M.A., Goggins W., Lobashevsky A., Sharfuddin A.A., Yaqub M.S., Mishler D.P., et al. The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients. Clin Transplant 2011, 25:E96-E102.
27. Fidler S.J., Irish A.B., Lim W., Ferrari P., Witt C.S., Christiansen F.T. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Transpl Immunol Jun. 2013, 28(4):148-153.
28. O'Brien F.J., Lineen J., Kennedy C.M., Phelan P.J., Kelly P.O., Denton M.D., et al. Effect of perioperative blood transfusions on long term graft outcomes in renal transplant patients. Clin Nephrol 2012, 77:432-437.
29. Scornik J.C., Schold J.D., Bucci M., Meier-Kriesche H.U. Effects of blood transfusions given after renal transplantation. Transplantation 2009, 87:1381-1386.
30. Bushell A., Karim M., Kingsley C.I., Wood K.J. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 2003, 76:449-455.
31. Scornik J.C., Ireland J.E., Howard R.J., Pfaff W.W., Fennell R.S. Sensitization by blood transfusions in previously transplanted patients. Transplantation 1983, 35:505-506.
32. Qian Z., Lee C.Y., Murata K., Liu J., Fox-Talbot K., Wasowska B.A., et al. Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion. Transplantation 2006, 82:857-864.
33. Norda R., Schott U., Berseus O., Akerblom O., Nilsson B., Ekdahl K.N., et al. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma. Vox Sang 2012, 102:125-133.
34. Pandey P., Chaudhary R., Aggarwal A., Kumar R., Khetan D., Verma A. Transfusion-associated immunomodulation: quantitative changes in cytokines as a measure of immune responsiveness after one time blood transfusion in neurosurgery patients. Asian J Transf Sci 2010, 4:78-85.
35. Strait R.T., Hicks W., Barasa N., Mahler A., Khodoun M., Kohl J., et al. MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med 2011, 208:2525-2544.
36. Magee B.A., Martin J., Cole M.P., Morris K.G., Courtney A.E. Effects of HLA-matched blood transfusion for patients awaiting renal transplantation. Transplantation 2012, 94:1111-1116.
37. Scornik J.C. HLA-matched blood transfusions?. Transplantation 2012, 94:1085.
38. Sasaki H., Chikaraishi T., Furuhata S., Tsutsumi H., Miyano S., Nakazawa R., et al. Autologous blood transfusion for kidney transplant recipients. Transplant Proc 2008, 40:1371-1372.